* MabVax therapeutics expands phase I clinical trial
investigation for patients with pancreatic cancer to include
honorhealth research institute
Source text for Eikon:
Further company coverage:
The post BRIEF-MabVax therapeutics expands phase I clinical trial investigation for patients with pancreatic cancer appeared first on NASDAQ.